Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study — Shaji Kumar (2011) | RDL Network
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Shaji Kumar, Jin Lu, Yang Terry Liu, Max Bittrich, Juan Du, Hartmut Goldschmidt, Charalampia Kyriakou, Donna Reece, Kihyun Kım, María‐Victoria Mateos, Verónica González‐Calle, Wen-Ming Chen, Heinz Ludwig, Giampaolo Merlini, Silvia Mangiacavalli, Meletios A Dimopoulos, Eftathios Kastritis, Chang‐Ki Min, Graça Esteves, Andrew J. Yee, Noopur Raje, Emily Rosta, Anja Haltner, Chris Cameron, Brian G.M. Durie
Shaji Kumar, Hartmut Goldschmidt, M.‐V. Mateos, Verónica González‐Calle, Juan Du, Kihyun Kım, Giampaolo Merlini, Silvia Mangiacavalli, Chang‐Ki Min, Meletios A Dimopoulos, Efstathios Kastritis, Heinz Ludwig, Graça Esteves, Hiroshi Handa, Fernando Escalante, Carlos Fernández de Larrea Rodríguez, Michel Delforge, Chris Cameron, Anja Haltner, S. Vincent Rajkumar, Brian G.M. Durie
Brian G.M. Durie, Hartmut Goldschmidt, María‐Victoria Mateos, Verónica González, Juan Du, Kihyun Kım, Giampaolo Merlini, Silvia Mangiacavalli, Chang Ki Min, Meletios A Dimopoulos, Efstathios Kastritis, Heinz Ludwig, Graça Esteves, Hiroshi Handa, Fernando Escalante, Carlos Fernández de Larrea Rodríguez, Michel Delforge, Chris Cameron, S. Vincent Rajkumar, Shaji Kumar
Shaji Kumar, Jae Hoon Lee, Meletios A Dimopoulos, Evangelos Terpos, Efstathios Kastritis, Wee Joo Chng, Artur Jurczyszyn, Hiroshi Handa, Shuji Ozaki, Xavier Leleu, Philippe Moreau, Juan José Lahuerta, Chaim Shustik, Daniel D. Waller, Meral Beksaç, Ravi Vij, Kihyun Kım, Jin Seok Kim, Ashraf Badros, Melissa Alsina, Brian G.M. Durie
Discussion(0)
No comments yet. Be the first to comment.